Next Article in Journal
Regulation of the X Chromosome in the Germline and Soma of Drosophila melanogaster Males
Previous Article in Journal
Whole Exome Sequencing Identifies New Host Genomic Susceptibility Factors in Empyema Caused by Streptococcus pneumoniae in Children: A Pilot Study
Open AccessReview

Telomere Maintenance Mechanisms in Cancer

by Tiago Bordeira Gaspar 1,2,3,4,†, Ana Sá 1,2,4,†, José Manuel Lopes 1,2,3,5, Manuel Sobrinho-Simões 1,2,3,5, Paula Soares 1,2,4,* and João Vinagre 1,2,3
Cancer Signaling and Metabolism Group, Institute for Research and Innovation in Health Sciences (i3S), University of Porto, 4200-135 Porto, Portugal
Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal
Medical Faculty of University of Porto (FMUP), 4200-139 Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313 Porto, Portugal
Department of Pathology and Oncology, Centro Hospitalar São João, 4200-139 Porto, Portugal
Author to whom correspondence should be addressed.
These authors contributed equally.
Genes 2018, 9(5), 241;
Received: 14 March 2018 / Revised: 20 April 2018 / Accepted: 23 April 2018 / Published: 3 May 2018
(This article belongs to the Section Human Genomics and Genetic Diseases)
Tumour cells can adopt telomere maintenance mechanisms (TMMs) to avoid telomere shortening, an inevitable process due to successive cell divisions. In most tumour cells, telomere length (TL) is maintained by reactivation of telomerase, while a small part acquires immortality through the telomerase-independent alternative lengthening of telomeres (ALT) mechanism. In the last years, a great amount of data was generated, and different TMMs were reported and explained in detail, benefiting from genome-scale studies of major importance. In this review, we address seven different TMMs in tumour cells: mutations of the TERT promoter (TERTp), amplification of the genes TERT and TERC, polymorphic variants of the TERT gene and of its promoter, rearrangements of the TERT gene, epigenetic changes, ALT, and non-defined TMM (NDTMM). We gathered information from over fifty thousand patients reported in 288 papers in the last years. This wide data collection enabled us to portray, by organ/system and histotypes, the prevalence of TERTp mutations, TERT and TERC amplifications, and ALT in human tumours. Based on this information, we discuss the putative future clinical impact of the aforementioned mechanisms on the malignant transformation process in different setups, and provide insights for screening, prognosis, and patient management stratification. View Full-Text
Keywords: cancer; telomere; telomerase; promoter; TERT; TERC; alternative lengthening of telomeres (ALT); telomere maintenance mechanism (TMM); non-defined telomere maintenance mechanism (NDTMM) cancer; telomere; telomerase; promoter; TERT; TERC; alternative lengthening of telomeres (ALT); telomere maintenance mechanism (TMM); non-defined telomere maintenance mechanism (NDTMM)
Show Figures

Figure 1

MDPI and ACS Style

Gaspar, T.B.; Sá, A.; Lopes, J.M.; Sobrinho-Simões, M.; Soares, P.; Vinagre, J. Telomere Maintenance Mechanisms in Cancer. Genes 2018, 9, 241.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop